Entry |
|
Name |
Satraplatin (USAN/INN) |
Formula |
C4H6Cl2O4Pt. C6H13N. NH3
|
Exact mass |
499.0604
|
Mol weight |
500.2827
|
Structure |
|
Class |
Antineoplastic
DG01679 Platinum compound
|
Remark |
|
Efficacy |
Antineoplastic, Cell growth inhibitor |
Comment |
Platinum compound
DNA alkylator
|
Target |
DNA |
Interaction |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01X OTHER ANTINEOPLASTIC AGENTS
L01XA Platinum compounds
L01XA04 Satraplatin
D05807 Satraplatin (USAN/INN)
Drug groups [BR:br08330]
Antineoplastic
DG01679 Platinum compound
D05807 Satraplatin
|
Other DBs |
|
KCF data |
ATOM 19
1 N1a N 31.6400 -20.0900
2 C1y C 30.4276 -20.7900
3 C1x C 29.2151 -20.0900
4 C1x C 30.4276 -22.1900
5 C1x C 28.0027 -20.7900
6 C1x C 28.0027 -22.1900
7 C1x C 29.2151 -22.8900
8 N0 N 31.5000 -17.2900
9 Z Pt 33.2500 -18.7600
10 O7a O 33.2500 -15.7500
11 X Cl 35.7000 -17.0800
12 X Cl 35.7000 -19.8800
13 O7a O 33.2500 -21.4200
14 C7a C 34.4624 -22.1200
15 C1a C 35.6579 -21.4296
16 O6a O 34.4625 -23.5198
17 C7a C 34.4624 -15.0500
18 C1a C 35.6749 -15.7500
19 O6a O 34.4624 -13.6502
BOND 17
1 1 2 1
2 2 3 1
3 2 4 1
4 3 5 1
5 5 6 1
6 6 7 1
7 7 4 1
8 9 10 1
9 9 11 1
10 9 12 1
11 9 13 1
12 13 14 1
13 14 15 1
14 14 16 2
15 10 17 1
16 17 18 1
17 17 19 2
|